The revenue in July for Zinzino‘s sales markets increased by 55 % and amounted to SEK 262.1 (169.1) million.
Faun Pharma’s external sales decreased and amounted to SEK 2.2 (10.3) million.
Overall, the Group increased by 64% and amounted to SEK 259.9 (158.8) million compared with the previous year.
Accumulated revenue for January – July 2025 increased by 57 % to SEK 1,780.1 (1,130.7) million.
Revenues were distributed as follows:
Regions, MSEK
25-Jul
24-Jul
Change
YTD 2025
YTD 2024
Change
The Nordics
26.1
23.4
12%
181.3
164.9
10%
Central Europe
76.1
44.1
73%
491.1
299.9
64%
East Europe
31.3
29.0
8%
217.8
220.6
-1%
South & West Europe
47.3
33.3
42%
309.3
193.6
60%
The Baltics
10.0
8.0
25%
66.8
55.5
20%
North America
47.2
16.7
183%
299.5
98.1
205%
Asia-Pacific
20.0
2.9
590%
169.0
28.2
499%
Africa
1.9
1.4
36%
12.1
8.3
46%
Zinzino
259.9
158.8
64%
1746.9
1069.1
63%
Faun Pharma
2.2
10.3
-79%
33.2
61.6
-46%
Zinzino Group
262.1
169.1
55%
1780.1
1130.7
57%
Countries in regions:
– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
– Central Europe: Austria, Germany, Switzerland
– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
– The Baltics: Estonia, Latvia, Lithuania
– North America: Canada, USA, Mexico
– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines
– Africa: South Africa
About Zinzino
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available in more than 100 markets across the world.
Zinzino has